ArticleTranslational lung cancer research2019

Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines.

Jordi Codony-Servat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.